Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
Open Access
- 23 April 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2021.00058
Abstract
Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic disorders. This study aimed to explore the role of metabolic disorders in screening advanced fibrosis in NAFLD patients.Keywords
This publication has 29 references indexed in Scilit:
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesJournal of Hepatology, 2015
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseaseJournal of Hepatology, 2014
- The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trialDiabetologia, 2014
- Dyslipidemia in Patients with Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease, 2012
- Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver diseaseJournal of Hepatology, 2009
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLDJournal of Hepatology, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionJournal of Hepatology, 2006
- Diagnosis and Management of the Metabolic SyndromeJournal of the American College of Cardiology, 2005
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndromeJournal of Hepatology, 2002
- Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosisJournal of Hepatology, 1994